Global Ulcerative Colitis Market Research Report 2023

Report ID: 1897707 | Published Date: Oct 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ulcerative Colitis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global Ulcerative Colitis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Drugs Stores
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ulcerative Colitis Market Perspective (2017-2028)
    2.2 Ulcerative Colitis Growth Trends by Region
        2.2.1 Ulcerative Colitis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ulcerative Colitis Historic Market Size by Region (2017-2022)
        2.2.3 Ulcerative Colitis Forecasted Market Size by Region (2023-2028)
    2.3 Ulcerative Colitis Market Dynamics
        2.3.1 Ulcerative Colitis Industry Trends
        2.3.2 Ulcerative Colitis Market Drivers
        2.3.3 Ulcerative Colitis Market Challenges
        2.3.4 Ulcerative Colitis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ulcerative Colitis Players by Revenue
        3.1.1 Global Top Ulcerative Colitis Players by Revenue (2017-2022)
        3.1.2 Global Ulcerative Colitis Revenue Market Share by Players (2017-2022)
    3.2 Global Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ulcerative Colitis Revenue
    3.4 Global Ulcerative Colitis Market Concentration Ratio
        3.4.1 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Revenue in 2021
    3.5 Ulcerative Colitis Key Players Head office and Area Served
    3.6 Key Players Ulcerative Colitis Product Solution and Service
    3.7 Date of Enter into Ulcerative Colitis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ulcerative Colitis Breakdown Data by Type
    4.1 Global Ulcerative Colitis Historic Market Size by Type (2017-2022)
    4.2 Global Ulcerative Colitis Forecasted Market Size by Type (2023-2028)
5 Ulcerative Colitis Breakdown Data by Application
    5.1 Global Ulcerative Colitis Historic Market Size by Application (2017-2022)
    5.2 Global Ulcerative Colitis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ulcerative Colitis Market Size (2017-2028)
    6.2 North America Ulcerative Colitis Market Size by Country (2017-2022)
    6.3 North America Ulcerative Colitis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ulcerative Colitis Market Size (2017-2028)
    7.2 Europe Ulcerative Colitis Market Size by Country (2017-2022)
    7.3 Europe Ulcerative Colitis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ulcerative Colitis Market Size (2017-2028)
    8.2 Asia-Pacific Ulcerative Colitis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ulcerative Colitis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ulcerative Colitis Market Size (2017-2028)
    9.2 Latin America Ulcerative Colitis Market Size by Country (2017-2022)
    9.3 Latin America Ulcerative Colitis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ulcerative Colitis Market Size (2017-2028)
    10.2 Middle East & Africa Ulcerative Colitis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ulcerative Colitis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Johnson & Johnson.
        11.1.1 Johnson & Johnson. Company Detail
        11.1.2 Johnson & Johnson. Business Overview
        11.1.3 Johnson & Johnson. Ulcerative Colitis Introduction
        11.1.4 Johnson & Johnson. Revenue in Ulcerative Colitis Business (2017-2022)
        11.1.5 Johnson & Johnson. Recent Development
    11.2 AbbVie
        11.2.1 AbbVie Company Detail
        11.2.2 AbbVie Business Overview
        11.2.3 AbbVie Ulcerative Colitis Introduction
        11.2.4 AbbVie Revenue in Ulcerative Colitis Business (2017-2022)
        11.2.5 AbbVie Recent Development
    11.3 Takeda Pharmaceuticals
        11.3.1 Takeda Pharmaceuticals Company Detail
        11.3.2 Takeda Pharmaceuticals Business Overview
        11.3.3 Takeda Pharmaceuticals Ulcerative Colitis Introduction
        11.3.4 Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
        11.3.5 Takeda Pharmaceuticals Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Ulcerative Colitis Introduction
        11.4.4 Roche Revenue in Ulcerative Colitis Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Warner Chilcott
        11.5.1 Warner Chilcott Company Detail
        11.5.2 Warner Chilcott Business Overview
        11.5.3 Warner Chilcott Ulcerative Colitis Introduction
        11.5.4 Warner Chilcott Revenue in Ulcerative Colitis Business (2017-2022)
        11.5.5 Warner Chilcott Recent Development
    11.6 Salix Pharmaceuticals/Santarus
        11.6.1 Salix Pharmaceuticals/Santarus Company Detail
        11.6.2 Salix Pharmaceuticals/Santarus Business Overview
        11.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Introduction
        11.6.4 Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2017-2022)
        11.6.5 Salix Pharmaceuticals/Santarus Recent Development
    11.7 Takeda
        11.7.1 Takeda Company Detail
        11.7.2 Takeda Business Overview
        11.7.3 Takeda Ulcerative Colitis Introduction
        11.7.4 Takeda Revenue in Ulcerative Colitis Business (2017-2022)
        11.7.5 Takeda Recent Development
    11.8 Ferring Pharmaceuticals
        11.8.1 Ferring Pharmaceuticals Company Detail
        11.8.2 Ferring Pharmaceuticals Business Overview
        11.8.3 Ferring Pharmaceuticals Ulcerative Colitis Introduction
        11.8.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
        11.8.5 Ferring Pharmaceuticals Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Ulcerative Colitis Introduction
        11.9.4 Pfizer Revenue in Ulcerative Colitis Business (2017-2022)
        11.9.5 Pfizer Recent Development
    11.10 InDeX Pharmaceuticals
        11.10.1 InDeX Pharmaceuticals Company Detail
        11.10.2 InDeX Pharmaceuticals Business Overview
        11.10.3 InDeX Pharmaceuticals Ulcerative Colitis Introduction
        11.10.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
        11.10.5 InDeX Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Ulcerative Colitis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Global Ulcerative Colitis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Ulcerative Colitis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Ulcerative Colitis Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Ulcerative Colitis Market Share by Region (2017-2022)
    Table 8. Global Ulcerative Colitis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Ulcerative Colitis Market Share by Region (2023-2028)
    Table 10. Ulcerative Colitis Market Trends
    Table 11. Ulcerative Colitis Market Drivers
    Table 12. Ulcerative Colitis Market Challenges
    Table 13. Ulcerative Colitis Market Restraints
    Table 14. Global Ulcerative Colitis Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Ulcerative Colitis Market Share by Players (2017-2022)
    Table 16. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis as of 2021)
    Table 17. Ranking of Global Top Ulcerative Colitis Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Ulcerative Colitis Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Ulcerative Colitis Product Solution and Service
    Table 21. Date of Enter into Ulcerative Colitis Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Ulcerative Colitis Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Ulcerative Colitis Revenue Market Share by Type (2017-2022)
    Table 25. Global Ulcerative Colitis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Ulcerative Colitis Revenue Market Share by Type (2023-2028)
    Table 27. Global Ulcerative Colitis Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Ulcerative Colitis Revenue Market Share by Application (2017-2022)
    Table 29. Global Ulcerative Colitis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Ulcerative Colitis Revenue Market Share by Application (2023-2028)
    Table 31. North America Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Ulcerative Colitis Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Ulcerative Colitis Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Johnson & Johnson. Company Detail
    Table 42. Johnson & Johnson. Business Overview
    Table 43. Johnson & Johnson. Ulcerative Colitis Product
    Table 44. Johnson & Johnson. Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 45. Johnson & Johnson. Recent Development
    Table 46. AbbVie Company Detail
    Table 47. AbbVie Business Overview
    Table 48. AbbVie Ulcerative Colitis Product
    Table 49. AbbVie Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 50. AbbVie Recent Development
    Table 51. Takeda Pharmaceuticals Company Detail
    Table 52. Takeda Pharmaceuticals Business Overview
    Table 53. Takeda Pharmaceuticals Ulcerative Colitis Product
    Table 54. Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 55. Takeda Pharmaceuticals Recent Development
    Table 56. Roche Company Detail
    Table 57. Roche Business Overview
    Table 58. Roche Ulcerative Colitis Product
    Table 59. Roche Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 60. Roche Recent Development
    Table 61. Warner Chilcott Company Detail
    Table 62. Warner Chilcott Business Overview
    Table 63. Warner Chilcott Ulcerative Colitis Product
    Table 64. Warner Chilcott Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 65. Warner Chilcott Recent Development
    Table 66. Salix Pharmaceuticals/Santarus Company Detail
    Table 67. Salix Pharmaceuticals/Santarus Business Overview
    Table 68. Salix Pharmaceuticals/Santarus Ulcerative Colitis Product
    Table 69. Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 70. Salix Pharmaceuticals/Santarus Recent Development
    Table 71. Takeda Company Detail
    Table 72. Takeda Business Overview
    Table 73. Takeda Ulcerative Colitis Product
    Table 74. Takeda Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 75. Takeda Recent Development
    Table 76. Ferring Pharmaceuticals Company Detail
    Table 77. Ferring Pharmaceuticals Business Overview
    Table 78. Ferring Pharmaceuticals Ulcerative Colitis Product
    Table 79. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 80. Ferring Pharmaceuticals Recent Development
    Table 81. Pfizer Company Detail
    Table 82. Pfizer Business Overview
    Table 83. Pfizer Ulcerative Colitis Product
    Table 84. Pfizer Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 85. Pfizer Recent Development
    Table 86. InDeX Pharmaceuticals Company Detail
    Table 87. InDeX Pharmaceuticals Business Overview
    Table 88. InDeX Pharmaceuticals Ulcerative Colitis Product
    Table 89. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
    Table 90. InDeX Pharmaceuticals Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ulcerative Colitis Market Share by Type: 2021 VS 2028
    Figure 2. Oral Features
    Figure 3. Injection Features
    Figure 4. Global Ulcerative Colitis Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Drugs Stores Case Studies
    Figure 7. Ulcerative Colitis Report Years Considered
    Figure 8. Global Ulcerative Colitis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Ulcerative Colitis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Ulcerative Colitis Market Share by Region: 2021 VS 2028
    Figure 11. Global Ulcerative Colitis Market Share by Players in 2021
    Figure 12. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Ulcerative Colitis Revenue in 2021
    Figure 14. North America Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Ulcerative Colitis Market Share by Country (2017-2028)
    Figure 16. United States Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Ulcerative Colitis Market Share by Country (2017-2028)
    Figure 20. Germany Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Ulcerative Colitis Market Share by Region (2017-2028)
    Figure 28. China Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Ulcerative Colitis Market Share by Country (2017-2028)
    Figure 36. Mexico Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Ulcerative Colitis Market Share by Country (2017-2028)
    Figure 40. Turkey Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Johnson & Johnson. Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 43. AbbVie Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 44. Takeda Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 45. Roche Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 46. Warner Chilcott Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 47. Salix Pharmaceuticals/Santarus Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 48. Takeda Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 49. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 51. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Takeda
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals
Frequently Asked Questions
Ulcerative Colitis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ulcerative Colitis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ulcerative Colitis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tysabri Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Natalizumab Drug

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Tysabri

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More